Prellis Biologics is a company that integrates human biology with machine learning to develop antibody therapeutics. Its bioprinted lymph node organoid platform recaptures the biology of the human immune system and allows to mine human antibody candidates in vitro. The platform enables B-cell activation and library creation, antibody screening selection, AI-guided screening and optimization, laser bioprinting, etc.